Associations between statins and COPD: a systematic review.
about
Statins in heart failure: do we need another trial?Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseLymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugsTemporal trends in hospitalization rates for older adults with chronic obstructive pulmonary diseaseStatins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studiesChronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.Update on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.Effects of mediterranean diet on lung function in smokers: a randomised, parallel and controlled protocolNovel simvastatin inhalation formulation and characterisationA polymorphism in HLA-G modifies statin benefit in asthma.The Effect of Statins on Blood Gene Expression in COPD.Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.Inflammatory markers and mortality among US adults with obstructive lung function.The effect of statins on chronic obstructive pulmonary disease exacerbation and mortality: a systematic review and meta-analysis of observational researchElevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Statins and morbidity and mortality in COPD in the COMIC study: a prospective COPD cohort study.Acute exacerbation of chronic obstructive pulmonary disease: cardiovascular links.Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.Emerging drugs for chronic obstructive pulmonary disease.Modifying the course of chronic obstructive pulmonary disease: looking beyond the FEV1.Lipid-lowering drug therapies and chronic obstructive pulmonary disease: lung failure or just heart failure?An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease.Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?A woman with breathlessness: a practical approach to diagnosis and management.Statins reduce all-cause mortality in chronic obstructive pulmonary disease: an updated systematic review and meta-analysis of observational studies.Paradigms in chronic obstructive pulmonary disease: phenotypes, immunobiology, and therapy with a focus on vascular disease.Statin reverses smoke-induced pulmonary hypertension and prevents emphysema but not airway remodeling.Reactive Oxygen Species in COPD-Related Vascular Remodeling.Target Fishing by Cross-Docking to Explain Polypharmacological Effects
P2860
Q26998966-A8F49A5D-0AD9-41A0-A3C0-1AD6BD675AD9Q27000043-584313A4-0DD0-4224-97FE-3DA46D5633B0Q28069399-880962E2-7BAB-431D-A917-33E1FC0D1B4FQ28391590-E88DC9A5-13F6-48F0-B2FB-7BED8C9EAC4EQ33986182-D30D2F2F-3A14-41B6-8D15-6D4B2C7BF8B9Q34039712-C3EE1703-A930-48C1-8978-00B9C621080CQ34656726-DC6A8C00-639F-47F2-96F6-6D33EA003AE1Q34989168-62D0439A-0E67-49D7-A91B-7AEB51FC2829Q35083428-75ABC213-318F-4236-8627-319982925134Q35164779-04302976-50D1-4396-B92A-870E99BEED5AQ35231686-A966AC9D-A3E2-434F-B4BF-7B5DE4F3DA6FQ35804958-8F00EEAD-FA0D-4FC1-90A7-DCE4D407CD64Q35897669-4276FA62-7FF9-4D55-83B1-377F2E393001Q36036012-54526B97-18C2-4DDB-BAE7-7390806C2002Q36265724-EAA2BB25-446F-4445-B363-964F81D49ADEQ36539136-12C0445B-D75A-4D66-8F6F-28704DC9CC4CQ37063674-059F5401-3A03-44AB-8639-E0C0D4E96399Q37644823-3D5BE5CF-8587-4AA2-B8F3-F94B1B6D8523Q37734257-28DDC027-6A23-4375-8CAB-8CA089F36E4CQ37984088-414D9835-F914-46CF-A0CE-BFCDD88EB280Q38041635-3E360E93-6977-4E18-AD0C-AD46881FAA13Q38181583-0CC9A9EC-AB1B-4F0E-ACAD-78BEEDA522D4Q38399184-B378D7D2-0C9E-42B9-8DDA-82EA1D41843AQ40771974-F242912B-EF4C-4ED4-BD3E-A586A6A2B051Q42253419-DD98569B-24DB-4E9D-90B8-64425D5694A8Q42700712-CD293A12-FE87-4C5E-A23A-A235EB9C99E0Q46165199-B99E12C9-6021-48CE-B1D6-D03AAA431288Q46227006-5A7857F2-68CF-4972-81D1-0BC61C171AC0Q46280803-3703BBB9-4C0F-42A5-AD0E-57CC4F70CBB7Q57010613-FDF1AF77-8DB4-4729-A905-EEEAB9467B15
P2860
Associations between statins and COPD: a systematic review.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Associations between statins and COPD: a systematic review.
@ast
Associations between statins and COPD: a systematic review.
@en
type
label
Associations between statins and COPD: a systematic review.
@ast
Associations between statins and COPD: a systematic review.
@en
prefLabel
Associations between statins and COPD: a systematic review.
@ast
Associations between statins and COPD: a systematic review.
@en
P2860
P50
P356
P1476
Associations between statins and COPD: a systematic review
@en
P2093
Guy B Marks
P2860
P2888
P356
10.1186/1471-2466-9-32
P577
2009-07-12T00:00:00Z
P5875
P6179
1018813912